Phase II study of paclitaxel and carboplatin for advanced non-small-cell lung cancer.
Laohavinij, S
Phase II study of paclitaxel and carboplatin for advanced non-small-cell lung cancer. [electronic resource] - Lung cancer (Amsterdam, Netherlands) Dec 1999 - 175-85 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article
0169-5002
10.1016/s0169-5002(99)00089-6 doi
Adenocarcinoma--drug therapy
Adult
Aged
Antineoplastic Agents, Phytogenic--administration & dosage
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Carboplatin--administration & dosage
Carcinoma, Non-Small-Cell Lung--drug therapy
Combined Modality Therapy
Female
Humans
Lung Neoplasms--drug therapy
Male
Middle Aged
Paclitaxel--administration & dosage
Pilot Projects
Prospective Studies
Phase II study of paclitaxel and carboplatin for advanced non-small-cell lung cancer. [electronic resource] - Lung cancer (Amsterdam, Netherlands) Dec 1999 - 175-85 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article
0169-5002
10.1016/s0169-5002(99)00089-6 doi
Adenocarcinoma--drug therapy
Adult
Aged
Antineoplastic Agents, Phytogenic--administration & dosage
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Carboplatin--administration & dosage
Carcinoma, Non-Small-Cell Lung--drug therapy
Combined Modality Therapy
Female
Humans
Lung Neoplasms--drug therapy
Male
Middle Aged
Paclitaxel--administration & dosage
Pilot Projects
Prospective Studies